{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:21:55Z","timestamp":1760188915937},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Ophthalmol"],"published-print":{"date-parts":[[2007,10,22]]},"DOI":"10.1007\/s12009-007-0018-5","type":"journal-article","created":{"date-parts":[[2007,8,30]],"date-time":"2007-08-30T19:37:45Z","timestamp":1188502665000},"page":"194-197","source":"Crossref","is-referenced-by-count":10,"title":["Intravenous Methylprednisolone Pulse Therapy for Acute Posterior Segment Uveitis Attacks in Beh\u00e7et\u2019s Disease"],"prefix":"10.1007","volume":"39","author":[{"given":"F. Nil\u00fbfer","family":"Yal\u00e7indag","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ertugrul","family":"Can","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6zden","family":"\u00d6zdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,9,1]]},"reference":[{"key":"18_CR1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF02912462","volume":"27","author":"R Rizzi","year":"1997","unstructured":"Rizzi R, Bruno S, Dammacco R. Beh\u00e7et\u2019s disease: an immune-mediated vasculitis involving vessels of all sizes. Int J Clin Lab Res 1997;27:225\u2013232","journal-title":"Int J Clin Lab Res"},{"key":"18_CR2","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1001\/archopht.1977.04450100115015","volume":"95","author":"DM Colvard","year":"1977","unstructured":"Colvard DM, Robertson DM, O\u2019Duffy JD. The ocular manifestations of Beh\u00e7et\u2019s disease. Arch Ophthalmol 1977;95:1813\u20131817","journal-title":"Arch Ophthalmol"},{"key":"18_CR3","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/archopht.1970.00990040453009","volume":"84","author":"JG Mamo","year":"1970","unstructured":"Mamo JG. The rate of visual loss in Beh\u00e7et\u2019s disease. Arch Ophthalmol 1970;84:451\u2013452","journal-title":"Arch Ophthalmol"},{"key":"18_CR4","first-page":"127","volume-title":"Posterior segment intraocular inflammation guidelines","author":"J Forrester","year":"1998","unstructured":"Forrester J, Okada A, BenEzra D, Ohno S. Posterior segment intraocular inflammation guidelines. The Hague: Kugler; 1998; pp. 127\u2013133"},{"key":"18_CR5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1053\/sarh.2001.19819","volume":"30","author":"VG Kaklamani","year":"2001","unstructured":"Kaklamani VG, Kaklamanis PG. Treatment of Beh\u00e7et\u2019s Disease\u2014an update. Semin Arthritis Rheum 2001;30:299\u2013312","journal-title":"Semin Arthritis Rheum"},{"key":"18_CR6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00063030-200115010-00003","volume":"15","author":"AI Russel","year":"2001","unstructured":"Russel AI, Lawson WA, Haskara DO. Potential new therapeutic options in Beh\u00e7et\u2019s Syndrome. BioDrugs 2001;15:25\u201335","journal-title":"BioDrugs"},{"key":"18_CR7","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000310145","volume":"201","author":"Y Sasamoto","year":"1990","unstructured":"Sasamoto Y, Ohno S, Matsuda H. Studies on corticosteroid therapy in Vogt-Koyanagi-Harada disease. Ophthalmologica 1990;201:162\u2013167","journal-title":"Ophthalmologica"},{"key":"18_CR8","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archopht.1986.01050180081035","volume":"104","author":"D Wakefield","year":"1986","unstructured":"Wakefield D, McClusky P, Penny R. Intravenous pulse methylprednisolone therapy in severe inflammatory eye disease. Arch Ophthalmol 1986;104:847\u2013851","journal-title":"Arch Ophthalmol"},{"key":"18_CR9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1442-9071.2000.00282.x","volume":"28","author":"D Wakefield","year":"2000","unstructured":"Wakefield D, Jennings A, McCluskey PJ. Intravenous pulse methylprednisolone in the treatment of uveitis associated with multiple sclerosis. Clin Exp Ophthalmol 2000;28:103\u2013106","journal-title":"Clin Exp Ophthalmol"},{"key":"18_CR10","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0002-9394(99)80163-9","volume":"125","author":"JB Reed","year":"1998","unstructured":"Reed JB, Morse LS, Schwab IR. High-dose intravenous pulse methylprednisolone hemisuccinate in acute Beh\u00e7et retinitis. Am J Ophthalmol 1998;125:409\u2013411","journal-title":"Am J Ophthalmol"},{"key":"18_CR11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/bjo.86.5.521","volume":"86","author":"E Toker","year":"2002","unstructured":"Toker E, Kozako\u011flu H, Acar N. High dose intravenous steroid therapy for severe posterior segment uveitis in Beh\u00e7et\u2019s disease. Br J Ophthalmol 2002;86:521\u2013523","journal-title":"Br J Ophthalmol"},{"key":"18_CR12","first-page":"1078","volume":"335","author":"International Study Group for Beh\u00e7et\u2019s Disease","year":"1990","unstructured":"International Study Group for Beh\u00e7et\u2019s Disease. Criteria for diagnosis of Beh\u00e7et\u2019s disease. Lancet 1990;335:1078\u20131080","journal-title":"Lancet"},{"key":"18_CR13","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/bjo.70.8.589","volume":"70","author":"D BenEzra","year":"1986","unstructured":"BenEzra D, Cohen E. Treatment and visual prognosis in Beh\u00e7et\u2019s disease. Br J Ophthalmol 1986;70:589\u2013592","journal-title":"Br J Ophthalmol"},{"key":"18_CR14","doi-asserted-by":"crossref","first-page":"613","DOI":"10.7326\/0003-4819-82-5-613","volume":"82","author":"GG Hunder","year":"1957","unstructured":"Hunder GG, Sheps SG, Allen GL, Joyce JW. Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis: comparison in a prospective study. Ann Intern Med 1957;82:613\u2013618","journal-title":"Ann Intern Med"},{"key":"18_CR15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1146\/annurev.pa.17.040177.002455","volume":"17","author":"JC Melby","year":"1977","unstructured":"Melby JC. Clinical pharmacology of systemic corticosteroids. Ann Rev Pharmacol Toxicol 1977;17:511\u2013527","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"18_CR16","first-page":"1","volume":"1","author":"D BenEzra","year":"1989","unstructured":"BenEzra D. Treatment of Beh\u00e7et\u2019s disease. Ophthalmology 1989;1:1\u20134","journal-title":"Ophthalmology"},{"key":"18_CR17","first-page":"1145","volume":"5","author":"SS Stubbs","year":"1973","unstructured":"Stubbs SS, Morrell RM. Intravenous methylprednisolone sodium succinate: adverse reactions reported in association with immunosuppressive therapy. Transplant Proc 1973;5:1145\u20131146","journal-title":"Transplant Proc"},{"key":"18_CR18","first-page":"677","volume":"23","author":"R Garrett","year":"1980","unstructured":"Garrett R, Paulus H. Complications of intravenous methylprednisolone pulse therapy, abstracted. Arthritis Rheum 1980;23:677","journal-title":"Arthritis Rheum"},{"key":"18_CR19","doi-asserted-by":"crossref","first-page":"781","DOI":"10.7326\/0003-4819-95-6-781_3","volume":"95","author":"RE Moses","year":"1981","unstructured":"Moses RE, McCormick A, Nickey W. Fatal arrhythmia after pulse methylprednisolone therapy. Ann Intern Med 1981;95:781\u2013782","journal-title":"Ann Intern Med"},{"key":"18_CR20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/art.1780260123","volume":"26","author":"AL Suchman","year":"1983","unstructured":"Suchman AL, Condemi JJ, Leddy JP. Seizure after pulse therapy with methylprednisolone. Arthritis Rheum 1983;26:117","journal-title":"Arthritis Rheum"}],"container-title":["Annals of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12009-007-0018-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12009-007-0018-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12009-007-0018-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T21:14:12Z","timestamp":1559423652000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12009-007-0018-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,1]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,10,22]]}},"alternative-id":["18"],"URL":"https:\/\/doi.org\/10.1007\/s12009-007-0018-5","relation":{},"ISSN":["1530-4086","1558-9951"],"issn-type":[{"value":"1530-4086","type":"print"},{"value":"1558-9951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,1]]}}}